European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
Contenuto archiviato il 2024-05-24

European multiple system atrophy study group

Obiettivo

Multiple system atrophy (MSA) is a progressive neurodegenerative disorder, which frequently presents with the features of Parkinson's Disease, but in contrast to latter, causes early death and prolonged severe disability. The proposed concerted action will pave the way towards neuroprotective intervention trials in MSA by developing a trial protocol 'CAPIT-MSA) and by implementing a central MSA Registry (EMSA-R) for centralized data acquisition during a multicoated natural history study that will enable us to define rates of disease progression and to validate the CAPIT-MSA protocol. Furthermore, candidate neuroprotective agents will be screened in proof of concept studies using an established animal model of striatonigral degeneration. Pending ongoing preclinical safety and phase I studies of these agents by the industrial partners, one of the agents will be selected foray multicoated safety and tolerability phase II trial commencing at month 18.

Campo scientifico

Programma(i)

Argomento(i)

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

CON - Coordination of research actions

Coordinatore

UNIVERSITY HOSPITAL INNSBRUCK
Contributo UE
Nessun dato
Indirizzo
Anichstrasse 35
6020 INNSBRUCK
Austria

Mostra sulla mappa
Costo totale
Nessun dato

Partecipanti (20)

Condividi questa pagina

Scarica

Ultimo aggiornamento: 12 Aprile 2005

Il mio booklet

Permalink: https://cordis.europa.eu/project/id/QLK6-CT-2000-00661/it

European Union, 2024